# NAS-BRCA-002 Platform Compatibility Audit Report 1.0.0

Decision: **changes required**  
Evidence access: **existing governed repository artifacts only**  
Molecular values or outcomes inspected: **no**

## Result

| State | Count |
|---|---:|
| Verified | 1 |
| Partial | 4 |
| Pending | 3 |

Complete PAM50 gene mapping is verified. The existing field-isolated receipt
resolved all 50 governed genes in GSE96058 with zero missing or ambiguous
canonical mappings, and the governed centroid candidate uses the same panel.

That is necessary but not sufficient for platform compatibility.

## Open compatibility requirements

- The alignment, quantification, transformation, normalization, and precision
  bridge is not locked.
- No independently justified platform-matched fixed reference or centering
  operation is locked.
- The performance-blind processed-input bridge to validation-only GSE96058 is
  not frozen.
- Assay QC and failure cutoffs remain dependent on a future selected workflow.
- Prospective blocked randomization and batch/run lineage are designed but do
  not yet exist.
- The Python synthetic kernel lacks an independent reference implementation and
  frozen numerical tolerances.
- Governed storage exists as infrastructure, but no calibration artifact
  manifest or retention receipt exists.

## Scientific interpretation

The audit prevents a common methodological error: treating “all genes are
present” as evidence that two expression sources are numerically interchangeable.
Gene presence supports feasibility only. Reference construction, centering,
expression scale, technical error, batch placement, numerical implementation,
and storage provenance remain separate dependencies.

The next locally resolvable item is independent numerical conformance. Reference,
assay-QC, and prospective-lineage closure will still require evidence not
currently present in the repository.

No source, platform stack, transformation, reference, threshold, or execution
authority was selected or claimed.
